Molecular mechanisms underlying mifepristone's agonistic action on ovarian cancer progression-Reference-Cited by-同舟云学术

Molecular mechanisms underlying mifepristone's agonistic action on ovarian cancer progression

Published:2019-09 Issue: Volume:47 Page:170-183
ISSN:2352-3964
Container-title:EBioMedicine
language:en
Short-container-title:EBioMedicine

Author:

Ponikwicka-Tyszko Donata,Chrusciel Marcin,Stelmaszewska Joanna,Bernaczyk Piotr,Chrusciel Paulina,Sztachelska Maria,Scheinin Mika,Bidzinski Mariusz,Szamatowicz Jacek,Huhtaniemi Ilpo T.,Wolczynski Slawomir,Rahman Nafis A.

Funder

National Science Centre

Academy of Finland

Moikoinen Cancer Research Foundation

EU PARP Cluster

National Science Centre, Poland

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference46 articles.

1. Phase II study of mifepristone (RU486) in refractory ovarian cancer;Rocereto;Gynecol Oncol,2000

2. A phase II evaluation of mifepristone in the treatment of recurrent or persistent epithelial ovarian, fallopian or primary peritoneal cancer: a gynecologic oncology group study;Rocereto;Gynecol Oncol,2010

3. Phase 2 trial of mifepristone (RU-486) in advanced or recurrent endometrioid adenocarcinoma or low-grade endometrial stromal sarcoma;Ramondetta;Cancer,2009

4. Mifepristone: contraceptive and noncontraceptive uses;Ho;Curr Opin Obstet Gynecol,2002

5. Phase II study of the progesterone antagonist mifepristone in patients with untreated metastatic breast carcinoma: a National Cancer Institute of Canada Clinical Trials Group study;Perrault;J Clin Oncol,1996

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PGRMC1 promotes NSCLC stemness phenotypes by disrupting TRIM56-mediated ubiquitination of AHR;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-10

2. Extra-nuclear and cytoplasmic steroid receptor signalling in hormone dependent cancers;The Journal of Steroid Biochemistry and Molecular Biology;2024-10

3. Effect of Mifepristone on Migration and Proliferation of Oral Cancer Cells;International Journal of Molecular Sciences;2024-08-12

4. Progesterone-mediated remodeling of the maternal-fetal interface by a PGRMC1-dependent mechanism;Journal of Reproductive Immunology;2024-06

5. Progesterone signaling in uterine leiomyoma biology: Implications for potential targeted therapy;Advances in Medical Sciences;2024-03